Genomics

Dataset Information

Capmatinib shows superior efficacy for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy.


ABSTRACT: Capmatinib shows superior efficacy for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy.

PROVIDER: PRJNA1060685 | ENA |

REPOSITORIES: ENA